Krka, d. d.

Previously, they were mostly produced in the Head Office of KRKA in Slovenia. Since May 17, all requirements of these drugs will be provided by Vektor-Medika CJSC – Novosibirsk producer of original drugs for the treatment of hepatitis B and C, cancer and viral infections.

26 May 2016
Novosibirsk Region, Moscow region

Investor profile

Krka, d. d.


Company's website:

T: +386 7 331 21 11

Public company


Contact: Jože Colarič, Director General

KRKA international pharmaceutical company is among world’s leading generic drug manufacturers, KRKA’s products are marketed in more than 70 countries, including Russia. KRKA has its own production and distribution centers in the Russian Federation.